Company Filing History:
5 out of 1,291 
4 out of 160 
1 out of 2,946 
Years Active: 1993-2003
Title: Klaus Eichmann: Innovator in Vaccine Development
Introduction
Klaus Eichmann is a prominent inventor based in Freiburg, Germany. He has made significant contributions to the field of vaccine development, particularly in the fight against Lyme disease. With a total of 7 patents to his name, Eichmann's work has the potential to impact public health positively.
Latest Patents
Eichmann's latest patents focus on innovative vaccines against Lyme disease. One of his notable inventions provides a vaccine that contains one or more monoclonal antibodies specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. This invention also outlines a process for obtaining the vaccine, along with new monoclonal antibodies and antigens. Another patent emphasizes hybridomas producing antibodies specific for Lyme disease antigens OspA, further enhancing the potential for effective vaccination against this disease.
Career Highlights
Throughout his career, Klaus Eichmann has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and the German Cancer Research Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Eichmann has collaborated with notable colleagues, including Markus M. Simon and Ulrich E. Schaible. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of scientific knowledge.
Conclusion
Klaus Eichmann's contributions to vaccine development, particularly against Lyme disease, highlight his role as a significant inventor in the field. His innovative patents and collaborations with leading research institutions underscore the importance of his work in advancing public health solutions.